BeyondSpring Presents Promising Data for Lead Asset Plinabulin at 2018 ASCO-SITC Clinical Immuno-Oncology Symposium

Source :: Plus Company Updates. January 29, 2018
Publication Year :: 2018
Abstract: NEW YORK : BeyondSpring Inc has issued the following press release: BeyondSpring Inc. (NASDAQ:BYSI), a global clinical-stage biopharmaceutical company focused on the development of innovative immuno-oncology cancer therapies, announced that [...]

Subjects :: Conferences and conventions -- Conferences, meetings and seminars
Chemotherapy -- Conferences, meetings and seminars
Medical research -- Conferences, meetings and seminars
General interest
News, opinion and commentary
Neulasta (Medication)

Tools